Back to top
more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$88.74 USD

88.74
1,093,175

+4.62 (5.49%)

Updated Aug 2, 2024 04:00 PM ET

After-Market: $88.71 -0.03 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (214 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

PDCO vs. MMSI: Which Stock Should Value Investors Buy Now?

PDCO vs. MMSI: Which Stock Is the Better Value Option?

Here's Why You Should Invest in Cardinal Health (CAH) Stock

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and strategic buyouts.

3 Reasons Why Growth Investors Shouldn't Overlook Merit Medical (MMSI)

Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

Zacks.com featured highlights include: Merit Medical Systems, Brinker International, Group 1 Automotive, Owens & Minor and HomeStreet

Zacks.com featured highlights include: Merit Medical Systems, Brinker International, Group 1 Automotive, Owens & Minor and HomeStreet

Anirudha Bhagat headshot

6 Stocks Near 52-Week Highs Poised to Appreciate Further

Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.

Here's Why Merit Medical (MMSI) is a Great Momentum Stock to Buy

Does Merit Medical (MMSI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Top Ranked Momentum Stocks to Buy for November 2nd

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 2nd

Merit Medical (MMSI) Soars to 52-Week High, Time to Cash Out?

Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Merit Medical (MMSI) Rallies 4.8% Post Q3 Earnings Beat

Merit Medical (MMSI) reported growth in revenues at Cardiovascular segment in the third quarter.

Merit Medical (MMSI) Q3 Earnings and Revenues Beat Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 121.05% and 11.38%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Merit Medical (MMSI) to Report a Decline in Earnings: What to Look Out for

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain Luminex (LMNX) Stock for Now

Investor confidence is high on Luminex (LMNX) stock, thanks to solid prospects.

Here's Why You Should Avoid Betting on Integer Holdings Now

Stiff competition in the MedTech space and weak segmental and operational performance weighs on Integer Holdings (ITGR).

Cerner Inks Deal to Simplify Advance Care Planning Procedure

Cerner's (CERN) partners with Vynca to simplify advance care planning process, thereby enabling patients and clinicians to discuss and make critical end-of-life decisions.

Zacks Value Trader Highlights: NortonLifeLock, Advance Auto Parts, Aecom, Green Dot and Merit Medical

Zacks Value Trader Highlights: NortonLifeLock, Advance Auto Parts, Aecom, Green Dot and Merit Medical

Sriparna Ghosal headshot

3 Great MedTech Stocks to Pick Amid the Coronavirus Crisis

Backed by projections of robust earnings growth rates, there are a few MedTech stocks which are ideal for long-term bet.

Tracey Ryniec headshot

Should Value Investors Buy SPACs?

Value hedge fund managers are launching SPACs in 2020 as value investors struggle to keep up with the return on growth stocks.

Baxter's Clinimix and Clinimix E Injections Receive FDA Nod

Baxter's (BAX) Clinimix and Clinimix E with Higher Protein Injection received FDA approval, which will help clinicians to improve care for critically ill patients.

Veeva CRM to Help Medis Deliver Customized Experience to HCPs

Veeva Systems' (VEEV) CRM will be lending Medis teams a flexible solution that adapts to the unique go-to market strategies of every customer.

Here's Why You Should Add NextGen Stock to Your Portfolio Now

Investor optimism is high on NextGen (NXGN) stock, thanks to solid prospects.

AngioDynamics Unveils Auryon Atherectomy System for PAD

AngioDynamics' (ANGO) Auryon Atherectomy System leverages breakthrough technology to deliver treatment of PAD lesions and occlusions.

Accuray's Radixact With Synchrony Used in Japan Hospitals

The integration of Synchrony to Accuray's (ARAY) Radixact System will ensure that the hospital teams can efficiently deliver precise radiation doses to tumors.

DexCom Introduces Registry to Monitor Outcomes of G6 System

DexCom (DXCM) sets up registry to track outcomes of patients and healthcare professionals using CGM in hospitals.

Here's Why You Should Retain Avanos Medical Stock for Now

Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.